Nakamura Tomoki, Kawai Akira, Sudo Akihiro
Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Tsu-city.
Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan.
Jpn J Clin Oncol. 2017 Nov 1;47(11):1055-1059. doi: 10.1093/jjco/hyx123.
The aim of this study was to elucidate the clinical outcomes of patients with STSs who received additional excisions after unplanned excisions (UE) using data from the Bone and Soft Tissue Tumor Registry in Japan.
We examined 197 patients with STSs who received an additional excision after a UE. Data from 2006 to 2013 were obtained from the BSTT Registry. There were 112 men and 85 women, with a mean age of 54 years. The mean primary tumor size was 4.7 cm. Tumor depth was classified as superficial (n = 132) or deep (n = 65).
Residual tumor cells were observed in 115 of 197 (58%) specimens at additional excision. Wide margins were achieved in 190 patients, whereas marginal or intra-lesional margins were made in seven patients. One hundred and five patients (53%) required plastic reconstructions. The 5-year disease-specific survival rate was 97.4%. Local recurrence occurred in 15 patients, and the 5-year local recurrence-free rate was 91%. Residual tumor tissue in re-excision specimens was an independent prognostic factor for local control (P = 0.04). The 5-year local recurrence-free rate was significantly worse in patients with residual tumors than in those without residual tumors.
We suggest that UEs should be avoided because they require additional excisions and, in many cases, subsequent soft tissue reconstruction. Additional excisions that are sufficiently extensive may improve local control, although patients with residual tumor tissue in re-excision specimens should be carefully followed up.
本研究旨在利用日本骨与软组织肿瘤登记处的数据,阐明在计划外切除(UE)后接受额外切除的软组织肉瘤(STS)患者的临床结局。
我们研究了197例在UE后接受额外切除的STS患者。从骨与软组织肿瘤登记处获取了2006年至2013年的数据。其中男性112例,女性85例,平均年龄54岁。原发肿瘤平均大小为4.7厘米。肿瘤深度分为浅表(n = 132)或深部(n = 65)。
在额外切除的197份标本中的115份(58%)中观察到残留肿瘤细胞。190例患者实现了广泛切缘,而7例患者为边缘或病灶内切缘。105例患者(53%)需要进行整形重建。5年疾病特异性生存率为97.4%。15例患者发生局部复发,5年无局部复发生存率为91%。再次切除标本中的残留肿瘤组织是局部控制的独立预后因素(P = 0.04)。有残留肿瘤的患者5年无局部复发生存率明显低于无残留肿瘤的患者。
我们建议应避免计划外切除,因为其需要额外切除,且在许多情况下需要后续软组织重建。足够广泛的额外切除可能会改善局部控制,不过对再次切除标本中有残留肿瘤组织的患者应进行密切随访。